Express Pharma

Zydus, Synthon sign licensing and supply pact for Palbociclib Tablets for US market

Synthon will be responsible for obtaining US regulatory approval for Palbociclib Tablets, and thereafter, for the manufacturing and supply of the product. Zydus will be responsible for commercialisation of the oncology product in the US